Coblation
Device Ent
PDI 00817470006445
General payments
$559,064
Research payments
$423,909
Through program year 2025, $559,064 in general payments and $423,909 in research payments were reported against Coblation (Ent).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $160,625 | 160 |
| 2025 | Research | $171,845 | 4 |
| 2024 | General | $174,574 | 323 |
| 2023 | General | $130,854 | 304 |
| 2023 | Research | $169,219 | 3 |
| 2022 | General | $92,175 | 155 |
| 2022 | Research | $82,845 | 5 |
| 2021 | General | $835 | 1 |
Breakdown
The top 5 of 52 recipients; each share is of general payments naming this product in 2025.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
943 general · 12 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.